Epstein-Barr virus infections after allogeneic stem cell transplantation: a comparison between non-malignant and malignant hematological disorders

Early cytomegalovirus infections following allogeneic stem cell transplantation: a comparison between non-malignant and malignant haematological disorders

(2010) Md Serajul Islam et al.   Hematology

Implications of CD34+ cell dose on clinical and haematological outcome of allo-SCT for acquired aplastic anaemia

(2009) M S Islam et al.   BONE MARROW TRANSPLANTATION

Guidelines for the diagnosis and management of aplastic anaemia

(2009) Judith C. W. Marsh et al.   BRITISH JOURNAL OF HAEMATOLOGY

Prior immunosuppressive therapy with antithymocyte globulin increases the risk of EBV-related lymphoproliferative disorder following allo-SCT for acquired aplastic anaemia

(2008) H C E Buyck et al.   BONE MARROW TRANSPLANTATION

EBV reactivation and post transplant lymphoproliferative disorders following allogeneic SCT

(2008) S Ocheni et al.   BONE MARROW TRANSPLANTATION

Epstein–Barr virus-associated lymphoproliferative disease after allogeneic haematopoietic stem cell transplantation: molecular monitoring and early treatment of high-risk patients

(2008) Ellen Meijer et al.   CURRENT OPINION IN HEMATOLOGY

Monitoring of Epstein-Barr virus load after hematopoietic stem cell transplantation for early intervention in post-transplant lymphoproliferative disease

(2008) Astrid Meerbach et al.   JOURNAL OF MEDICAL VIROLOGY